✦ LIBER ✦

An overview of 3 phase II trials of navelbine (NVB), and fractionated doses of cisplstin (CDDP) in the management of advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Pawlicki, M.; Rodrigues, J.; Firat, D.; Altino, J.; Krawczyk, K.; Le Bras, Barista F.; Burillon, J.P.; Delgado, F.M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

158 Phase II study of navelbine (NVB) an

✍ Murad, A.; Rodrigues, J.; Malzyner, A.; Caponero, R.; Yamaguchi, N.; Altino, J.; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 158 KB

63 Navelbine (NVB), and fractionated dos

✍ Rodrigues, J.; Pawlicki, M.; Firat, D.; Altino, J.; Krawczyk, K.; Barista, ; Le 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 159 KB

A phase I-II trial of cisplatin (CDDP),

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 180 KB

A phase II study of navelbine® (NVB) and

✍ Depperman, KM; Kurzeja, A; Krause, K; Müller, U; Le Bras, F; Delchambre, J; Barb 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 257 KB

A phase II study of navelbine® (NVB) and

✍ Deppermann, KM; Kurzeja, A; Krause, K; Müller, U; Le Bras, F; Delchambre, J; Bar 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 132 KB

A phase I/II trial of carboplatin and na

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB